Unexplained Liver Inflammation
Blood work shows elevated liver enzymes with no clear cause, such as viral hepatitis, alcohol use, or fatty liver disease, and your doctor wants to check for autoimmune causes.
AI Summary Anti-LKM-1 is the autoantibody most closely linked to type 2 autoimmune hepatitis, a form most common in children and young people, but a positive result cannot confirm the disease alone because diagnosis also needs symptoms, elevated IgG, liver biopsy findings, and exclusion of other liver diseases, according to LiverDirectory's Autoimmune Hepatitis guide and AASLD guidelines.
Source: www.liverdirectory.com
Medically Reviewed.
The anti-LKM (liver/kidney microsomal antibody) test looks for antibodies your immune system makes against proteins found in liver and kidney cells. The main antibody in this group, anti-LKM-1, is most closely tied to type 2 autoimmune hepatitis, a form of the disease that most often starts in childhood or young adulthood.
A positive anti-LKM-1 result doesn't confirm autoimmune hepatitis on its own. Doctors weigh it alongside other autoantibodies, immunoglobulin G (IgG) levels, liver blood tests, and often a liver biopsy before making a diagnosis.
This page explains what the anti-LKM test measures, when doctors order it, how results are interpreted, how type 2 autoimmune hepatitis compares with type 1, and what typically happens after a positive or negative result.
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
Anti-LKM Antibody Basics
The anti-LKM (liver/kidney microsomal antibody) test is a blood test that looks for autoantibodies — proteins your immune system mistakenly directs against your own tissue. The antibody this test targets, anti-LKM-1, binds to an enzyme found on liver and kidney cells (CYP2D6) and is the antibody most closely linked to type 2 autoimmune hepatitis, a less common subtype of autoimmune hepatitis that most often begins in childhood or young adulthood, though it can appear at any age.
Doctors rarely order anti-LKM by itself. It's typically one part of an autoimmune liver disease panel, which usually also includes antinuclear antibody (ANA), smooth muscle antibody (ASMA), antimitochondrial antibody (AMA), and serum immunoglobulin G (IgG). No single antibody in this panel confirms autoimmune hepatitis; each one narrows down which subtype is most likely and helps rule out other liver conditions.
Reasons Doctors Order It
Your doctor may order an anti-LKM test in several situations.
Blood work shows elevated liver enzymes with no clear cause, such as viral hepatitis, alcohol use, or fatty liver disease, and your doctor wants to check for autoimmune causes.
Type 2 autoimmune hepatitis, the subtype linked to anti-LKM-1, is most common in children and young people, so it's often part of the initial workup in this age group.
Your ANA and ASMA results came back negative, but the clinical picture still points to autoimmune hepatitis. Anti-LKM-1 is the antibody most often found in the subset of cases that ANA and ASMA testing miss.
You've already been diagnosed with autoimmune hepatitis, and your doctor wants to confirm whether it's type 1 or type 2, since this can influence how closely you're monitored.
Blood Draw and Lab Method
The anti-LKM test uses a blood sample drawn from a vein, the same way as other antibody tests like ANA or ASMA. No fasting or special preparation is typically needed, though your lab or doctor may give specific instructions.
Laboratories detect anti-LKM-1 using immunoassay methods that identify antibodies bound to liver and kidney cell proteins. Results are usually reported as positive or negative, sometimes with a titer (a measure of antibody concentration) that can help gauge how strongly the immune system is reacting.
Because no single antibody confirms autoimmune hepatitis, anti-LKM is almost always ordered alongside ANA, ASMA, AMA, and IgG level testing so your doctor can build a complete picture rather than relying on one result.
Autoimmune Antibody Panel
Doctors rarely rely on one antibody alone. Anti-LKM is usually ordered together with other tests to build a full picture and to help distinguish autoimmune hepatitis subtypes.
Antibody results are combined with liver blood tests, symptoms, and often a liver biopsy — no single test confirms autoimmune hepatitis on its own.
Anti-LKM Result Interpretation
Points toward type 2 autoimmune hepatitis, especially when paired with elevated liver enzymes and high IgG. A positive result alone doesn't confirm the diagnosis; your doctor will combine it with symptoms, IgG levels, and usually a liver biopsy.
Does not rule out autoimmune hepatitis. Most people with autoimmune hepatitis have type 1 disease, which is linked to ANA and ASMA rather than anti-LKM-1, so a negative anti-LKM result simply points your doctor toward other antibodies or causes.
Uncommon. When it happens, doctors weigh the full clinical picture — symptoms, IgG level, and biopsy findings — rather than antibody positivity alone to determine the likely subtype and treatment approach.
A titer describes how concentrated the antibody is in your blood. Higher titers can support a stronger suspicion of autoimmune hepatitis, but titer level alone doesn't determine disease severity or guide treatment decisions on its own.
Autoimmune Hepatitis Care Pathway
Type 1 is the most common form of autoimmune hepatitis and is linked to ANA and/or ASMA. It can start at any age but often begins in young adulthood, and people with type 1 frequently have other autoimmune conditions, such as thyroiditis or rheumatoid arthritis. Type 2 is linked to anti-LKM-1 and anti-LC1, is less common overall, and is seen mostly in children and young people, though adults can develop it too. Both types respond to immune-suppressing treatment, but doctors may monitor type 2 more closely given its tendency to appear earlier in life.
Autoimmune hepatitis often causes no symptoms in its early stages. When symptoms do appear, they can include fatigue, abdominal discomfort, joint pain, jaundice, itching, an enlarged liver, nausea, loss of appetite, and dark urine. Because these symptoms overlap with many other liver conditions, antibody tests like anti-LKM are often what point doctors toward an autoimmune cause.
Diagnosis is a composite assessment, not a single test. Doctors combine characteristic symptoms, autoantibody results such as anti-LKM-1, an elevated IgG level, and liver biopsy findings that show interface hepatitis (inflammation at the border between liver cells and surrounding tissue). They also rule out other causes of liver disease, including viral hepatitis, drug-induced liver injury, and metabolic conditions, before confirming autoimmune hepatitis.
First-line treatment for both types is a corticosteroid, such as prednisone, often combined with azathioprine once bilirubin levels allow it. Adding azathioprine lets doctors use a lower steroid dose, reducing side effects like weight gain, bone thinning, and high blood pressure. Many people need treatment for years, and biochemical markers can rise again if medication stops, so doctors monitor bloodwork closely during and after tapering. If medication doesn't control the disease, or if cirrhosis or liver failure develops, a liver transplant may become necessary.
A balanced, liver-friendly diet supports your liver, helps manage weight and blood sugar, and lowers the risk of other health problems during long-term follow-up.
Explore Liver DietThe Amsety Bar is a liver-friendly snack or meal replacement that can make it easier to eat well on busy days.
Shop Amsety Bars
Common Questions
Anti-LKM stands for anti-liver/kidney microsomal antibody. It's an autoantibody your immune system can mistakenly produce against proteins found in liver and kidney cells. The main type, anti-LKM-1, is strongly linked to type 2 autoimmune hepatitis.
No. A positive anti-LKM result raises suspicion for type 2 autoimmune hepatitis, but doctors confirm the diagnosis using a composite of symptoms, IgG levels, other antibody results, and usually a liver biopsy.
Type 1 is linked to ANA and ASMA and is the most common form overall. Type 2 is linked to anti-LKM-1 and anti-LC1 and is more common in children and young adults. Both types respond to immune-suppressing medication, though monitoring can differ by subtype.
A titer measures antibody concentration in your blood. Higher titers can support a stronger suspicion of autoimmune hepatitis, but the titer alone doesn't determine disease severity or dictate your treatment plan — your doctor weighs it alongside symptoms, IgG levels, and biopsy findings.
Treatment usually starts with a corticosteroid, often combined with azathioprine once bilirubin levels allow it, to reduce the steroid dose and its side effects. Most people need long-term treatment, and a liver transplant may be considered if the disease progresses to liver failure despite treatment.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.